Mirum Pharmaceuticals Inc’s filing revealed that its Director Ramasastry Saira unloaded Company’s shares for reported $0.4 million on Dec 22 ’25. In the deal valued at $80.00 per share,5,000 shares were sold. As a result of this transaction, Ramasastry Saira now holds 0 shares worth roughly $0.0.
Then, GREY MICHAEL G sold 50,000 shares, generating $3,900,000 in total proceeds. Upon selling the shares at $78.00, the Director now owns 0 shares.
Before that, SAIRA RAMASASTRY bought 5,000 shares. Mirum Pharmaceuticals Inc shares valued at $400,000 were divested by the Director at a price of $80.00 per share.
TD Cowen initiated its Mirum Pharmaceuticals Inc [MIRM] rating to a Buy in a research note published on September 24, 2025; the price target was $95. Stifel started covering the stock on April 17, 2024. It rated MIRM as “a Buy”.
Price Performance Review of MIRM
On Tuesday, Mirum Pharmaceuticals Inc [NASDAQ:MIRM] saw its stock fall -1.70% to $78.85. Over the last five days, the stock has lost -2.74%. Mirum Pharmaceuticals Inc shares have risen nearly 87.60% since the year began. Nevertheless, the stocks have risen 90.69% over the past one year. While a 52-week high of $82.58 was reached on 12/23/25, a 52-week low of $36.88 was recorded on 04/09/25.
Levels Of Support And Resistance For MIRM Stock
The 24-hour chart illustrates a support level at 78.01, which if violated will result in even more drops to 77.18. On the upside, there is a resistance level at 79.91. A further resistance level may holdings at 80.98.
How much short interest is there in Mirum Pharmaceuticals Inc?
A steep rise in short interest was recorded in Mirum Pharmaceuticals Inc stocks on 2025-12-15, dropping by -0.29 million shares to a total of 7.37 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 7.66 million shares. There was a decline of -3.89%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 18, 2023 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $58.
